Journal article
Colchicine in Patients with Chronic Coronary Disease
Abstract
BACKGROUND: Evidence from a recent trial has shown that the antiinflammatory effects of colchicine reduce the risk of cardiovascular events in patients with recent myocardial infarction, but evidence of such a risk reduction in patients with chronic coronary disease is limited.
METHODS: In a randomized, controlled, double-blind trial, we assigned patients with chronic coronary disease to receive 0.5 mg of colchicine once daily or matching …
Authors
Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu X-F; Ireland MA; Lenderink T
Journal
The New England Journal of Medicine, Vol. 383, No. 19, pp. 1838–1847
Publisher
Massachusetts Medical Society
Publication Date
November 5, 2020
DOI
10.1056/nejmoa2021372
ISSN
0028-4793